Citius Oncology, Inc.
CTOR
$0.70
$0.022.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.53M | -5.00M | -5.37M | -7.74M | -6.66M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 573.40K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.22M | 2.56M | 2.39M | 2.35M | 2.07M |
| Change in Net Operating Assets | -6.61M | -3.06M | 2.98M | 5.38M | 4.59M |
| Cash from Operations | -7.35M | -5.49M | 0.00 | 0.00 | 0.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.40M | -5.75M | -- | -- | -- |
| Cash from Investing | -4.40M | -5.75M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.13M | 15.17M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.13M | 15.17M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.37M | 3.92M | -- | -- | -- |